Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Tests Available in the US NIPT Market
     3.1 MaterniT21
     3.2 Verifi
     3.3 Panorama
     3.4 Harmony

4. Current Technologies in the Market

5. Association of Down’s syndrome Risk to Fetus with Mother's Age

6. Demographics Outlook
     6.1 Population Demographics
     6.2 Number of Births: Current and Future
            6.2.1 By Age Group
            6.2.2 By State
     6.3 Disease Demographics

7. US NIPT - Potential Market (2014 & 2020)

8. US NIPT Market Projections to 2020
     8.1 Market Size and Forecast
     8.2 Market Share of Players

9. Regulatory Insight
     9.1 Current Regulatory Scenario
     9.2 Regulatory Authority Perspective
     9.3 Diagnostic Test Provider Perspective
     9.4 ACOG Opinion
     9.5 Consumers’ Perspective
     9.6 Analyst Inputs

10. Reimbursement Scenario for US NIPT Market

11. Competitive Assessment
     11.1 Ariosa Diagnostics
            11.1.1 Business Overview
            11.1.2 Strengths and Weaknesses
            11.1.3 Recent Developments
     11.2 Sequenom
            11.2.1 Business Overview
            11.2.2 Strengths and Weaknesses
            11.2.3 Recent Developments
     11.3 Verinata
            11.3.1 Business Overview
            11.3.2 Strengths and Weaknesses
            11.3.3 Recent Developments
     11.4 Natera
            11.4.1 Business Overview
            11.4.2 Strengths and Weaknesses
            11.4.3 Recent Developments